New: NCI-funded clinical trial search
Mednet Logo
CommunityPrimary Care

How do you manage endocrine therapy in patients on tamoxifen who develop thrombophlebitis but not DVT?

How do you decide on resumption or change of therapy?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of North Carolina at Chapel Hill
Answered on

In a patient on tamoxifen, the risk of clot extension into the deep system is higher than average. In such scenarios, the recommendation is to use anticoagulation for at least 6 weeks (consider 3 months if no improvement noted at 6 weeks). Tamoxifen should be held for the first 3 weeks, consider res...

Join for free or sign in to see the full answer